Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel
Cancer Treatment Reviews · 2026-11 · 150 · 103216
DOI: 10.1016/j.ctrv.2026.103216 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-11. Verfasst von Francesco Mattana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Taxoids, Prostatic Neoplasms, Castration-Resistant, Dipeptides, Heterocyclic Compounds, 1-Ring. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.
- Medical Oncology Unit, Edoardo Agnelli Hospital, Pinerolo, Italy.
- Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy. Electronic address: valentino.dragonetti@ieo.it.
- Department of Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
- Chief of Medical Oncology, Cardinal Massaia Hospital, Asti, Italy.
- Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
Zitieren
APA
Mattana, F., Palesandro, E., Dragonetti, V., Curigliano, G., Tucci, M., & Ceci, F. (2026). Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel. Cancer Treatment Reviews, 150, 103216. https://doi.org/10.1016/j.ctrv.2026.103216
Vancouver
Mattana F, Palesandro E, Dragonetti V, Curigliano G, Tucci M, Ceci F. Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel. Cancer Treatment Reviews. 2026;150:103216. doi:10.1016/j.ctrv.2026.103216
BibTeX
@article{Mattana2026,
author = {Mattana, Francesco and Palesandro, Erica and Dragonetti, Valentino and Curigliano, Giuseppe and Tucci, Marcello and Ceci, Francesco},
title = {Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {150},
pages = {103216},
doi = {10.1016/j.ctrv.2026.103216}
}
EUVIMED